Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy

被引：5

作者：

Rubinstein, Jeremy D. ^{[1
,2
]}

Zhu, Xiang ^{[3
]}

Lutzko, Carolyn ^{[1
,3
]}

Leemhuis, Tom ^{[4
]}

Cancelas, Jose A. ^{[1
,3
,4
]}

Jodele, Sonata ^{[1
,2
]}

Bollard, Catherine M. ^{[5
,6
]}

Hanley, Patrick J. ^{[5
,6
]}

Davies, Stella M. ^{[1
,2
]}

Grimley, Michael S. ^{[1
,2
]}

Nelson, Adam S. ^{[1
,2
]}

机构：

[1] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA

[2] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Canc & Blood Dis Inst, 3333 Burnet Ave,MLC 7015, Cincinnati, OH 45229 USA

[3] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Expt Hematol, Cincinnati, OH 45229 USA

[4] Univ Cincinnati, Hoxworth Blood Ctr, Cincinnati, OH USA

[5] Childrens Natl Hlth Syst, Ctr Canc & Immunol Res, Washington, DC USA

[6] George Washington Univ, Dept Pediat, Washington, DC 20052 USA

来源：

BLOOD ADVANCES | 2020年 / 4卷 / 14期

基金：

美国国家卫生研究院;

关键词：

THROMBOTIC MICROANGIOPATHY; TRANSPLANTATION; INFECTIONS; BLOCKADE; TMA;

D O I：

10.1182/bloodadvances.2020002252

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3252 / 3257

页数：6

共 50 条

[1] Toward the understanding of a successful virus-specific T-cell therapy: T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy
Poiret, Thomas
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) : 139 - 140
[2] Monitoring of virus-specific T-cells with virus specific tetramers - implication for virus-specific T-cell therapy?
Borchers, S.
Grabow, B.
Luther, S.
Heuer, M.
Ganser, A.
Weissinger, E. M.
BONE MARROW TRANSPLANTATION, 2007, 39 : S167 - S167
[3] VIRUS-SPECIFIC T-CELL SENSITIZATION - REQUIREMENTS FOR VACCINIA VIRUS-SPECIFIC T-CELL SENSITIZATION INVIVO
ERTL, HCJ
GERIKE, RHW
KOSZINOWSKI, UH
IMMUNOGENETICS, 1977, 4 (06) : 515 - 522
[4] Confirmation of High Resolution Antiviral HLA Restrictions Correlates with Antiviral Responses Following Virus-Specific T-Cell Therapy
Keller, Michael D.
Hanley, Patrick J.
Lang, Haili
Hoq, Fahmida
Lynwood, Jhaminique
Bollard, Catherine M.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[5] Virus-specific T-cell therapy in solid organ transplantation
Roemhild, Andy
Reinke, Petra
TRANSPLANT INTERNATIONAL, 2016, 29 (05) : 515 - 526
[6] Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised
Koukoulias, Kiriakos
Papayanni, Penelope Georgia
Leen, Ann Marie
Vasileiou, Spyridoula
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024,
[7] The role of virus-specific adoptive T-cell therapy in hematopoietic transplantation
Sellar, Rob S.
Peggs, Karl S.
CYTOTHERAPY, 2012, 14 (04) : 391 - 400
[8] PML: BK Virus-specific T-Cell Therapy successfully used
Lichert, Frank
TRANSFUSIONSMEDIZIN, 2021, 11 (04)
[9] Hepatitis C virus-specific cytolytic T cell responses after antiviral therapy
Morishima, C
Musey, L
Elizaga, M
Gaba, K
Allison, M
Carithers, RL
Gretch, DR
McElrath, MJ
CLINICAL IMMUNOLOGY, 2003, 108 (03) : 211 - 220
[10] T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy
Keller, Michael D.
Darko, Sam
Lang, Haili
Ransier, Amy
Lazarski, Christopher A.
Wang, Yunfei
Hanley, Patrick J.
Davila, Blachy J.
Heimall, Jennifer R.
Ambinder, Richard F.
Barrett, A. John
Rooney, Cliona M.
Heslop, Helen E.
Douek, Daniel C.
Bollard, Catherine M.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) : 206 - 218

← 1 2 3 4 5 →